2023-04-04 07:29:16 ET
- The U.S. Food and Drug Administration (FDA) approved ANI Pharmaceuticals' ( NASDAQ: ANIP ) generic cholesterol-lowering drug, Colestipol Hydrochloride Tablets USP 1 g.
- The company said its Colestipol Hydrochloride tablets are the generic version of the reference listed drug (RLD) Colestid.
- "We are pleased to expand our generics portfolio with the launch of Colestipol, bringing to market a product with a limited number of suppliers," said ANI President and CEO Nikhil Lalwani.
- ANIP +2.01% to 39.60 premarket April 4
For further details see:
ANI Pharma's generic cholesterol-lowering drug gets FDA approval